162
Views
21
CrossRef citations to date
0
Altmetric
SPACE RADIATION EFFECTS ON COAGULATION

The effects of proton radiation on the prothrombin and partial thromboplastin times of irradiated ferrets

, &
Pages 327-334 | Received 17 May 2011, Accepted 06 Dec 2011, Published online: 06 Feb 2012

References

  • Arsenian MA. 1991. Cardiovascular sequelae of therapeutic thoracic radiation. Progress in Cardiovascular Disease 33:299–311.
  • Carlson RG, Mayfield W, Normann S. 1991. Radiation-associated valvular disease. Chest 99:538–545.
  • Carr ZA, Land CE, Kleinerman RA. 2005. Coronary heart disease after radiotherapy for peptic ulcer disease. International Journal of Radiation Oncology, Biology, Physics 61:842–850.
  • Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, . 2005. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. The Lancet 366:2087–2106.
  • Davie EW, Fujikawa K, Kisiel W. 1991. The coagulation cascade: Initiation, maintenance, and regulation. Biochemistry 30:10363.
  • Denson KW. 1969. Abnormal forms of factor X. The Lancet 2:1256.
  • Denson KW, Lurie A, De Cataldo F, Mannucci PM. 1970. The factor-X defect: Recognition of abnormal forms of factor X. British Journal of Haematology 18:317–27.
  • Early Breast Cancer Trialists’ Collaborative Group. 2002. Radiotherapy for early breast cancer. Cochrane Database of Systematic Reviews: CD003647.
  • Fajardo LF, Lee A. 1975. Rupture of major vessels after radiation. Cancer 36:904–913.
  • Furie B, Furie B. 1988. The molecular basis of blood coagulation. Cell 53:505–518.
  • Glanzmann C, Kaufmann P, Jenni R. 1998. Caridac risk after mediastinal irradiation for Hodgkin's disease. Radiotherapy Oncology 46:51–62.
  • Goldin-Lang P, Niebergal F, Antoniak S, Szotowski B, Rosenthal P, Pels K, Schultheiss H-P, Rauch U. 2007. Ionizing radiation induces upregulation of cellular procoagulability and tissue factor expression in human peripheral blood mononuclear cells. Thrombosis Research 120:857–864.
  • Hancock SL, Donaldson SS, Hoppe RT. 1993. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. Journal of Clinical Oncology 11:1208–1215.
  • Hellweg CE, Baumstark-Khan C. 2007. Getting ready for the manned mission to Mars: The astronauts’ risk from space radiation. Naturwissenschaften 94.
  • Hoffman M, Monroe DM III. 2001. A cell-based model of hemostasis. Journal of Thrombosis and Haemostasis 85: 958–965.
  • Hu S, Kim M-HY, McClellan GE, Cucinotta FA. 2009. Modeling the acute health effects of astronauts from exposure to large solar particle events. Health Physics 96:465–476.
  • Hull MC, Morris CG, Pepine CJ. 2003. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. Journal of the American Medical Association 290:2831–2837.
  • Ivanov V. 2006. The risk of radiation-induced cerebrovascular disease in Chernobyl emergency workers. Health Physics 90:199–207.
  • Jahroudi N, Ardekani AM, Greenberger JS. 1996. Ionizing Irradaition Increases Transcription of the von Willebrand Factor Gene in Endothelial Cells. Blood 88:3801–3814.
  • Lawler A. 2010. Obama backs new launcher And bigger NASA budget. Science 327.
  • Lipshultz SE, Sallan SE. 1993. Cardiovascular abnormalities in long-term survivors of childhood malignancy. Journal of Clinical Oncology 11:1199–1203.
  • Mannucci PM, Duga S, Peyvandi F. 2004. Recessively inherited coagulation disorders. Blood 104:1243–1252.
  • Muirhead C, O'Hagan J, Haylock R. 2009. Mortality and cancer incidence following occupational radiation exposure: Third analysis of the National Registry for Radiation Workers. British Journal of Cancer 100:206–212.
  • Ng V. 2009. Liver disease, coagulation testing, and hemostasis. Clin Lab Med 29:265–282.
  • Patel DA, Kochanski J, Suen AW. 2005. Clinical manifestations of noncoronary atherosclerotic vascular disease after moderate dose irradiation. Cancer 106:718–725.
  • Pehlivanov B, Milchev N, Kroumov G. 2004. Factor VII deficiency and its treatment in delivery with recombinant factor VII. European Journal of Obstetrics and Gynecology and Reproductive Biology 116:237–238.
  • Preston DL, Shimizu Y, Pierce DA. 2003. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality. Radiation Research 160:381–407.
  • Reinders JG, Heijmen BJ, Olofsen-van Acht MJ. 1999. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow up. Radiotherapy Oncology 51:35–42.
  • Rithidech KN, Honikel L, Rieger R, Xie W, Fischer T, Simon S. 2009. Protein-expression profiles in mouse blood-plasma following acute whole-body exposure to 137Cs γ-rays. International Journal of Radiation Biology 85:432–447.
  • Shimizu Y, Pierce DA, Preston DL. 1999. Studies of the mortality of atomic bomb survivors. Report 12, Part II. Noncancer mortality: 1950–1990. Radiation Research 152:374–389.
  • Sporn IA, Rubin P, Marder VJ. 1984. Irradiation induces release of von Willebrand protein from endothelial cells in culture. Blood 64:567.
  • Stewart H, Fajardo LF. 1984. Radiation-induced heart disease. Progress in Cardiovascular Disease 27:173–194.
  • Thomas G, DeLoughery M. 2004. Coagulation defects in trauma patients: Etiology, recognition, and therapy. Critical Care Clinics 20:13–24.
  • Turner RE, Baker JC. 1998. Solar particle events and the International Space Station. Acta Astronautica 42:107–114.
  • Weisbach V, Strobel J, Hahn B. 2007. Effect of gamma irradiation with 30 Gy on the coagulation system in leukoreduced fresh-frozen plasma. Transfusion 47:1658–1665.
  • White G, Beebe A, Nielsen B. 1997. Recombinant factor IX. Thrombosis and Haemostasis 78:261–265.
  • White G, Shapiro A, Ragni M, Garzone P, Goodfellow J, Tubridy K, Courter S. 1998. Clinical evaluation of recombinant factor IX. Seminars in Hematology 35:33–38.
  • Yuan S, Ferrell C, Chandler W. 2007. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma. Thrombosis Research 120:29–37.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.